[1]
Kian, M. et al. 2022. Molecular docking and mouse modeling suggest CMKLR1 and INSR as targets for improving PCOS phenotypes by minocycline. EXCLI Journal. 21, (Feb. 2022), 400–414. DOI:https://doi.org/10.17179/excli2021-4534.